title: Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors.
abstract: The objective of this study was to evaluate nuclear reactivity of Mdm2 and p53 proteins by immunohistochemical means in feline mammary gland tumors; 12 adenomas which included 6 adenomatous lesions obtained from the tissue adjacent to adenocarcinomas, and 22 adenocarcinomas. Seven adenomas and 18 adenocarcinomas showed moderate or marked Mdm2 reactivity. Sixteen adenocarcinomas showed moderate to marked p53 reactivity, but 9 adenomas showed none. Discordant Mdm2 overexpression was found in 5 adenomas and 3 adenocarcinomas, although co-overexpression of Mdm2 and p53 was found in 15 adenocarcinomas. These results suggest that nuclear overexpression of Mdm2 is present in the tumors of early stage without p53 overexpression and related to feline mammary gland tumorigenesis. Nuclear overexpression of p53 is more frequent in adenocarcinomas, but not in adenomas.
authors.affiliation: The United Graduate School of Veterinary Sciences, Yamaguchi University, Japan.
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Nakano
authors.forename: Haiyan
authors.initials: H
authors.lastname: Wu
authors.forename: Yasuho
authors.initials: Y
authors.lastname: Taura
authors.forename: Makoto
authors.initials: M
authors.lastname: Inoue
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry / Q000473:pathology / Q000662:veterinary*; D000236:Adenoma / Q000737:chemistry / Q000473:pathology / Q000662:veterinary*; D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis; D002371:Cat Diseases / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D002415:Cats; D005260:Female; D007150:Immunohistochemistry / Q000662:veterinary; D015674:Mammary Neoplasms, Animal / Q000737:chemistry / Q000209:etiology / Q000473:pathology*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000032:analysis*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53; D051736:Proto-Oncogene Proteins c-mdm2